GB2153821A - 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives - Google Patents
3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives Download PDFInfo
- Publication number
- GB2153821A GB2153821A GB08501889A GB8501889A GB2153821A GB 2153821 A GB2153821 A GB 2153821A GB 08501889 A GB08501889 A GB 08501889A GB 8501889 A GB8501889 A GB 8501889A GB 2153821 A GB2153821 A GB 2153821A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methyl
- compound
- group
- formula
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (11)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848401888A GB8401888D0 (en) | 1984-01-25 | 1984-01-25 | Heterocyclic compounds |
GB848425959A GB8425959D0 (en) | 1984-10-15 | 1984-10-15 | Heterocyclic compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8501889D0 GB8501889D0 (en) | 1985-02-27 |
GB2153821A true GB2153821A (en) | 1985-08-29 |
GB2153821B GB2153821B (en) | 1988-01-20 |
Family
ID=26287221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08501889A Expired GB2153821B (en) | 1984-01-25 | 1985-01-25 | 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives |
Country Status (29)
Country | Link |
---|---|
KR (1) | KR920003064B1 (en) |
AT (1) | AT392276B (en) |
AU (1) | AU579132B2 (en) |
BE (1) | BE901576A (en) |
CA (1) | CA1252793A (en) |
CH (1) | CH664152A5 (en) |
CY (1) | CY1479A (en) |
CZ (1) | CZ404391A3 (en) |
DE (2) | DE19375046I2 (en) |
DK (1) | DK169521B1 (en) |
ES (3) | ES8609309A1 (en) |
FI (1) | FI84349C (en) |
FR (1) | FR2561244B1 (en) |
GB (1) | GB2153821B (en) |
GR (1) | GR850219B (en) |
HK (1) | HK33189A (en) |
HU (1) | HU193592B (en) |
IE (1) | IE57809B1 (en) |
IL (1) | IL74165A (en) |
IT (1) | IT1182150B (en) |
LU (2) | LU85743A1 (en) |
NL (2) | NL190373C (en) |
NO (2) | NO164025C (en) |
NZ (1) | NZ210940A (en) |
PH (1) | PH22672A (en) |
PT (1) | PT79890B (en) |
SE (1) | SE460359B (en) |
SG (1) | SG7089G (en) |
SK (1) | SK277923B6 (en) |
Cited By (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0191562A2 (en) * | 1985-01-23 | 1986-08-20 | Glaxo Group Limited | Tetrahydrocarbazolone derivatives |
EP0210840A2 (en) | 1985-07-24 | 1987-02-04 | Glaxo Group Limited | Substituted imidazolylmethyltetrahydro-carbazolones |
EP0219193A1 (en) * | 1985-07-24 | 1987-04-22 | Glaxo Group Limited | Tetrahydrocarbazolone derivatives, processes for their preparation and pharmaceutical compositions containing them |
EP0219929A1 (en) * | 1985-07-24 | 1987-04-29 | Glaxo Group Limited | Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones |
EP0221629A1 (en) * | 1985-07-24 | 1987-05-13 | Glaxo Group Limited | Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones |
EP0226266A2 (en) * | 1985-06-25 | 1987-06-24 | Glaxo Group Limited | Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments |
EP0229444A2 (en) * | 1985-07-24 | 1987-07-22 | Glaxo Group Limited | Medicaments for the treatment of anxiety |
US4721720A (en) * | 1985-03-14 | 1988-01-26 | Beecham Group P.L.C. | Method of treating emesis, anxiety and/or IBS |
FR2601951A1 (en) * | 1986-07-23 | 1988-01-29 | Glaxo Group Ltd | NOVEL TETRAHYDROCARBAZOLONES, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PROCESS FOR PREPARING THE SAME |
FR2602142A1 (en) * | 1986-07-30 | 1988-02-05 | Sandoz Sa | THERAPEUTIC USE OF 5HT3 SEROTONINERGIC RECEPTOR ANTAGONISTS |
EP0266899A2 (en) * | 1986-10-03 | 1988-05-11 | Glaxo Group Limited | Indole derivatives |
EP0269452A2 (en) * | 1986-11-28 | 1988-06-01 | Glaxo Group Limited | Use of ketone derivatives for the manufacture of medicaments |
WO1988003801A1 (en) * | 1986-11-21 | 1988-06-02 | Glaxo Group Limited | Medicaments for treatment or prevention of withdrawal syndrome |
EP0275668A2 (en) * | 1986-12-17 | 1988-07-27 | Glaxo Group Limited | Use of ketone derivatives in the treatment of cognitive disorders |
EP0275669A1 (en) * | 1986-12-17 | 1988-07-27 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
EP0278173A2 (en) * | 1986-12-17 | 1988-08-17 | Glaxo Group Limited | Use of heterocyclic derivatives in the treatment of depressions |
EP0278161A1 (en) * | 1986-11-21 | 1988-08-17 | Glaxo Group Limited | Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome |
FR2611366A1 (en) * | 1986-11-28 | 1988-09-02 | Glaxo Group Ltd | NOVEL TRICYCLIC CETONES USEFUL AS MEDICAMENTS, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION |
EP0295836A2 (en) * | 1987-06-16 | 1988-12-21 | Btg International Limited | Use of dioxopiperidine derivatives for the manufacture of topical medicaments as analgesics |
FR2617713A1 (en) * | 1987-07-11 | 1989-01-13 | Sandoz Sa | NEW USE OF 5HT-3 ANTAGONISTS |
EP0317088A1 (en) * | 1987-10-22 | 1989-05-24 | Glaxo Group Limited | Ketone derivatives |
US4835173A (en) * | 1986-12-17 | 1989-05-30 | Glaxo Group Limited | Method of medical treatment |
FR2627986A1 (en) * | 1988-03-04 | 1989-09-08 | Glaxo Group Ltd | PHARMACEUTICAL COMPOSITION OF 1,2,3,9-TETRAHYDRO-9-METHYL-3 - ((2-METHYL-1H-IMIDAZOL-1-YL) METHYL) -4H-CARBAZOL-4-ONE OR ONE OF ITS SALTS AND DEXAMETHASONE, PREPARATION METHOD AND USES THEREOF |
EP0338650A1 (en) * | 1988-04-22 | 1989-10-25 | Duphar International Research B.V | New imidazolylmethyl-cycloalkane(b)indolones |
EP0339959A2 (en) * | 1988-04-27 | 1989-11-02 | Glaxo Group Limited | Lactam derivatives |
US4892872A (en) * | 1987-10-22 | 1990-01-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoxazine compounds and pharmaceutical use thereof |
EP0361317A2 (en) * | 1988-09-27 | 1990-04-04 | Fujisawa Pharmaceutical Co., Ltd. | Pyridoindole derivatives and processes for preparation thereof |
US4918079A (en) * | 1987-10-02 | 1990-04-17 | Beecham Group P.L.C. | Imidazole derivatives as 5-HT3 receptor antagonists |
US4918080A (en) * | 1987-04-14 | 1990-04-17 | Glaxo Group Limited | Imidazollyl containing ketone derivatives |
FR2639944A1 (en) * | 1988-12-06 | 1990-06-08 | Adir | NOVEL INDOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
EP0376624A1 (en) * | 1988-12-22 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | 4,5,6,7-Tetrahydrobenzimidazole derivatives and their preparation |
EP0377238A1 (en) * | 1988-12-22 | 1990-07-11 | Duphar International Research B.V | New annelated indolo (3,2-c)-lactams |
EP0392663A1 (en) * | 1989-03-13 | 1990-10-17 | Ono Pharmaceutical Co., Ltd. | Carboline derivative as a 5-HT3 receptor antagonist |
WO1990012569A1 (en) * | 1989-04-21 | 1990-11-01 | Sandoz Ag | Therapeutic use of 5-ht3 receptor antagonists |
EP0411901A2 (en) * | 1989-08-01 | 1991-02-06 | Glaxo Group Limited | Treatment of conditions involving excessive eating |
WO1991005783A1 (en) | 1989-10-14 | 1991-05-02 | John Wyeth & Brother Limited | Heterocyclic compounds |
WO1991009593A2 (en) * | 1989-12-21 | 1991-07-11 | Beecham Group Plc | 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability |
US5045545A (en) * | 1988-05-27 | 1991-09-03 | Glaxo Group Limited | [(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activity |
EP0451538A2 (en) * | 1990-03-19 | 1991-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Use of pyridoindole derivatives in the treatment of ischemic disorders |
US5116984A (en) * | 1988-04-07 | 1992-05-26 | Glaxo Group Limited | Imidazole derivatives |
US5126343A (en) * | 1989-09-11 | 1992-06-30 | G. D. Searle & Co. | N-azabicyclo [3.3.0]octane amides of aromatic acids |
US5187166A (en) * | 1990-07-31 | 1993-02-16 | Nisshin Flour Milling Co., Ltd. | Azabicyclo derivatives and their use as antiemetics |
US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US5202343A (en) * | 1986-11-28 | 1993-04-13 | Glaxo Group Limited | Tricyclic ketones useful as HT3 -receptor antagonists |
US5204356A (en) * | 1985-07-24 | 1993-04-20 | Glaxo Group Limited | Treatment of anxiety |
US5223625A (en) * | 1988-12-22 | 1993-06-29 | Duphar International Research B.V. | Annelated indolo [3,2,-C]lactams |
US5225431A (en) * | 1987-10-23 | 1993-07-06 | Burroughs Wellcome Co. | Therapeutic substituted indole compounds and compositions thereof |
AT396870B (en) * | 1986-08-07 | 1993-12-27 | Sandoz Ag | Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists |
US5276050A (en) * | 1989-08-01 | 1994-01-04 | Glaxo Group Limited | Medicaments |
US5290785A (en) * | 1988-09-27 | 1994-03-01 | Fujisawa Pharmaceutical Co., Ltd. | Therapeutic agent for ischemic diseases |
EP0345956B1 (en) * | 1988-05-20 | 1994-03-16 | Glaxo Group Limited | Tricyclic ketones |
EP0591434A1 (en) * | 1991-06-26 | 1994-04-13 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
EP0595111A1 (en) * | 1992-10-14 | 1994-05-04 | Richter Gedeon Vegyeszeti Gyar R.T. | Carbazolone derivatives and process for preparing the same |
GB2279008A (en) * | 1993-05-25 | 1994-12-21 | Glaxo Lab Sa | Compositions |
US5391549A (en) * | 1992-03-12 | 1995-02-21 | Mitsubishi Kasei Corporation | Cinnoline-3-carboxylic acid derivatives |
EP0688216A1 (en) * | 1993-03-08 | 1995-12-27 | Fujisawa Pharmaceutical Co., Ltd. | Medicament for treating or preventing cerebrovascular diseases |
FR2727015A1 (en) * | 1994-11-22 | 1996-05-24 | Glaxo Wellcome Inc | ONDANSETRON LIQUID PHARMACEUTICAL COMPOSITIONS |
US5578632A (en) * | 1985-06-25 | 1996-11-26 | Glaxo Group Limited | Medicaments for the treatment of gastrointestinal dysfunction |
EP0768309A1 (en) * | 1995-10-13 | 1997-04-16 | Duphar International Research B.V | Process for the preparation of enantiomerically pure imidazolyl compounds |
US5622720A (en) * | 1989-06-28 | 1997-04-22 | Glaxo Group Limited | Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
GB2325408A (en) * | 1994-06-28 | 1998-11-25 | Kenneth Francis Prendergast | Chewing gum formulation comprising ondansetron for combat use |
US6365743B1 (en) | 1995-10-13 | 2002-04-02 | Duphar International Research B.V. | Process for the preparation of enantiomerically pure imidazolyl compounds |
EP1207160A1 (en) * | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
US6548082B1 (en) | 1999-03-01 | 2003-04-15 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron |
NL1022893C2 (en) * | 2003-01-09 | 2004-07-13 | Synthon Bv | Forms of ondansetron and processes for making these. |
GB2398071A (en) * | 2003-01-24 | 2004-08-11 | Synthon Bv | Preparation of ondansetron |
WO2005080381A1 (en) * | 2004-01-21 | 2005-09-01 | Inke, S.A. | New polymorphic forms of ondansetron, processes for preparing them, pharmaceutical compositions containing them and their use as antiemetics |
US7098345B2 (en) | 2002-04-29 | 2006-08-29 | TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one |
WO2007004041A2 (en) * | 2005-07-05 | 2007-01-11 | Orchid Research Laboratories Limited | New compounds and their pharmaceutical use |
EP2253316A1 (en) | 2009-05-20 | 2010-11-24 | INSERM (Institut National de la Santé et de la Recherche Medicale) | serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of vestibular deficits |
WO2010133663A1 (en) | 2009-05-20 | 2010-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
ES2043535B1 (en) * | 1992-03-13 | 1994-08-01 | Vita Invest Sa | PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA. |
HU212934B (en) | 1992-10-14 | 1996-12-30 | Richter Gedeon Vegyeszet | Process for producing novel alkoxalylated carbazolone derivatives |
US5969137A (en) * | 1996-09-19 | 1999-10-19 | Virginia Commonwealth University | Benzylamidine derivatives with serotonin receptor binding activity |
CA2565854A1 (en) | 2004-05-07 | 2005-11-17 | Taro Pharmaceutical Industries Ltd. | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
CN115611864A (en) * | 2022-11-01 | 2023-01-17 | 常州兰陵制药有限公司 | Ondansetron compound and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3634420A (en) * | 1969-05-09 | 1972-01-11 | American Cyanamid Co | 3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones |
US3740404A (en) * | 1969-05-09 | 1973-06-19 | American Cyanamid Co | Piperidinomethylenedihydrocarbazolones |
AU583343B2 (en) * | 1985-01-23 | 1989-04-27 | Glaxo Group Limited | Heterocyclic compounds |
-
1985
- 1985-01-25 IL IL74165A patent/IL74165A/en not_active IP Right Cessation
- 1985-01-25 NZ NZ210940A patent/NZ210940A/en unknown
- 1985-01-25 AT AT204/85A patent/AT392276B/en not_active IP Right Cessation
- 1985-01-25 AU AU38097/85A patent/AU579132B2/en not_active Expired
- 1985-01-25 LU LU85743A patent/LU85743A1/en active Protection Beyond IP Right Term
- 1985-01-25 DE DE1993175046 patent/DE19375046I2/en active Active
- 1985-01-25 ES ES539852A patent/ES8609309A1/en not_active Expired
- 1985-01-25 CH CH346/85A patent/CH664152A5/en not_active IP Right Cessation
- 1985-01-25 IT IT47600/85A patent/IT1182150B/en active Protection Beyond IP Right Term
- 1985-01-25 LU LU88268C patent/LU88268I2/xx unknown
- 1985-01-25 DK DK035785A patent/DK169521B1/en not_active IP Right Cessation
- 1985-01-25 FR FR8501056A patent/FR2561244B1/en not_active Expired
- 1985-01-25 DE DE19853502508 patent/DE3502508A1/en active Granted
- 1985-01-25 HU HU85296A patent/HU193592B/en unknown
- 1985-01-25 GR GR850219A patent/GR850219B/el active IP Right Revival
- 1985-01-25 IE IE187/85A patent/IE57809B1/en not_active IP Right Cessation
- 1985-01-25 PH PH31770A patent/PH22672A/en unknown
- 1985-01-25 NO NO850300A patent/NO164025C/en not_active IP Right Cessation
- 1985-01-25 PT PT79890A patent/PT79890B/en unknown
- 1985-01-25 NL NLAANVRAGE8500202,A patent/NL190373C/en not_active IP Right Cessation
- 1985-01-25 SE SE8500368A patent/SE460359B/en not_active IP Right Cessation
- 1985-01-25 BE BE0/214394A patent/BE901576A/en not_active IP Right Cessation
- 1985-01-25 CA CA000472888A patent/CA1252793A/en not_active Expired
- 1985-01-25 FI FI850323A patent/FI84349C/en not_active IP Right Cessation
- 1985-01-25 KR KR1019850000454A patent/KR920003064B1/en not_active IP Right Cessation
- 1985-01-25 GB GB08501889A patent/GB2153821B/en not_active Expired
- 1985-10-31 ES ES548430A patent/ES8708224A1/en not_active Expired
-
1986
- 1986-06-16 ES ES556101A patent/ES8801247A1/en not_active Expired
-
1989
- 1989-02-09 SG SG70/89A patent/SG7089G/en unknown
- 1989-04-20 HK HK331/89A patent/HK33189A/en not_active IP Right Cessation
- 1989-07-21 CY CY1479A patent/CY1479A/en unknown
-
1991
- 1991-12-23 SK SK4043-91A patent/SK277923B6/en unknown
- 1991-12-23 CZ CS914043A patent/CZ404391A3/en unknown
-
1994
- 1994-05-31 NL NL940009C patent/NL940009I2/en unknown
- 1994-11-09 NO NO1994022C patent/NO1994022I1/en unknown
Cited By (144)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0191562A2 (en) * | 1985-01-23 | 1986-08-20 | Glaxo Group Limited | Tetrahydrocarbazolone derivatives |
EP0191562A3 (en) * | 1985-01-23 | 1987-05-27 | Glaxo Group Limited | Tetrahydrocarbazolone derivatives |
US4721720A (en) * | 1985-03-14 | 1988-01-26 | Beecham Group P.L.C. | Method of treating emesis, anxiety and/or IBS |
US4783478A (en) * | 1985-03-14 | 1988-11-08 | Beecham Group P.L.C. | Treatment of emesis, nausea and vomiting |
US4851407A (en) * | 1985-03-14 | 1989-07-25 | Beecham Group, P.L.C. | Novel treatment |
EP0385517A3 (en) * | 1985-03-14 | 1990-10-31 | Beecham Group P.L.C. | Medicaments for the treatment of emesis |
EP0385517A2 (en) * | 1985-03-14 | 1990-09-05 | BEECHAM GROUP plc | Medicaments for the treatment of emesis |
US4929632A (en) * | 1985-06-25 | 1990-05-29 | Glaxo Group Limited | Medicaments |
US4753789A (en) * | 1985-06-25 | 1988-06-28 | Glaxo Group Limited | Method for treating nausea and vomiting |
EP0226266A2 (en) * | 1985-06-25 | 1987-06-24 | Glaxo Group Limited | Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments |
AU609028B2 (en) * | 1985-06-25 | 1991-04-26 | Glaxo Group Limited | New medical use of tetrahydrocarbazolones derivative |
EP0431443A2 (en) * | 1985-06-25 | 1991-06-12 | Glaxo Group Limited | Use of tetrahydrocarbazolone derivatives for the manufacture of medicaments |
US5578632A (en) * | 1985-06-25 | 1996-11-26 | Glaxo Group Limited | Medicaments for the treatment of gastrointestinal dysfunction |
EP0431443A3 (en) * | 1985-06-25 | 1991-09-18 | Glaxo Group Limited | Use of tetrahydrocarbazolone derivatives for the manufacture of medicaments |
AT395374B (en) * | 1985-06-25 | 1992-12-10 | Glaxo Group Ltd | PHARMACEUTICAL PREPARATION |
EP0226266A3 (en) * | 1985-06-25 | 1990-01-24 | Glaxo Group Limited | Use of tetrahydrocarbazolone derivatives for the manufacture of medicaments |
US6569883B1 (en) * | 1985-06-25 | 2003-05-27 | Glaxo Group Limited | Medicaments |
US5411968A (en) * | 1985-07-24 | 1995-05-02 | Glaxo Group Limited | Treatment of anxiety |
EP0221629A1 (en) * | 1985-07-24 | 1987-05-13 | Glaxo Group Limited | Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones |
EP0229444A2 (en) * | 1985-07-24 | 1987-07-22 | Glaxo Group Limited | Medicaments for the treatment of anxiety |
US4883803A (en) * | 1985-07-24 | 1989-11-28 | Glaxo Group Limited | Treatment of anxiety |
EP0229444A3 (en) * | 1985-07-24 | 1990-11-28 | Glaxo Group Limited | Medicaments for the treatment of anxiety |
EP0219929A1 (en) * | 1985-07-24 | 1987-04-29 | Glaxo Group Limited | Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones |
EP0219193A1 (en) * | 1985-07-24 | 1987-04-22 | Glaxo Group Limited | Tetrahydrocarbazolone derivatives, processes for their preparation and pharmaceutical compositions containing them |
US5204356A (en) * | 1985-07-24 | 1993-04-20 | Glaxo Group Limited | Treatment of anxiety |
EP0210840A2 (en) | 1985-07-24 | 1987-02-04 | Glaxo Group Limited | Substituted imidazolylmethyltetrahydro-carbazolones |
EP0210840A3 (en) * | 1985-07-24 | 1987-06-10 | Glaxo Group Limited | Substituted imidazolylmethyltetrahydro-carbazolones |
BE1000730A5 (en) * | 1986-07-23 | 1989-03-21 | Glaxo Group Ltd | NOVEL TETRAHYDROCARBAZOLONES, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THEIR PREPARATION. |
FR2601951A1 (en) * | 1986-07-23 | 1988-01-29 | Glaxo Group Ltd | NOVEL TETRAHYDROCARBAZOLONES, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PROCESS FOR PREPARING THE SAME |
DE3724059A1 (en) * | 1986-07-30 | 1988-02-18 | Sandoz Ag | USE OF mono- and bicyclic carbocyclic and heterocyclic CARBONSAEUREESTERN and amides OF NITROGEN CONTAINING ALCOHOLS AND AMINES AND THEIR SAEUREADDITIONSSALZEN and quaternary ammonium salts, AND OF IMIDAZOLYL carbazoles for treating psychiatric disorders such as SOCIAL withdrawal symptoms, bipolar disorders, PSYCHOSIS AND OTHER RELATED TO STRESS STANDING DISEASES, DISEASES OF WAKE STATE LIKE GERIATRIC DISEASES, REMOTE FOR TREATING RHINITIS, LUNG EMBOLICS AND IMPROVING THE NASAL RESORPTION OF OTHER ACTIVE SUBSTANCES .......... |
GB2231265A (en) * | 1986-07-30 | 1990-11-14 | Sandoz Ltd | Therapeutic use of serotonin antagonists |
FR2602142A1 (en) * | 1986-07-30 | 1988-02-05 | Sandoz Sa | THERAPEUTIC USE OF 5HT3 SEROTONINERGIC RECEPTOR ANTAGONISTS |
GB2231265B (en) * | 1986-07-30 | 1991-04-24 | Sandoz Ltd | Therapeutic use of serotonin-antagonists |
GB2193633A (en) * | 1986-07-30 | 1988-02-17 | Sandoz Ltd | Therapeutic use of serotonin antagonists |
GB2231264B (en) * | 1986-07-30 | 1991-04-24 | Sandoz Ltd | Pharmaceutical compositions containing anti-serotonin indolyl derivatives |
BE1005921A4 (en) * | 1986-07-30 | 1994-03-15 | Sandoz Sa | THERAPEUTIC USE OF serotonin 5HT3 RECEPTOR ANTAGONISTS. |
GB2231264A (en) * | 1986-07-30 | 1990-11-14 | Sandoz Ltd | Therapeutic use of serotonin antagonists |
GB2193633B (en) * | 1986-07-30 | 1991-04-17 | Sandoz Ltd | Psycho-active pharmaceutical compositions containing indolyl derivatives |
AT396870B (en) * | 1986-08-07 | 1993-12-27 | Sandoz Ag | Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists |
EP0266899A2 (en) * | 1986-10-03 | 1988-05-11 | Glaxo Group Limited | Indole derivatives |
EP0266899A3 (en) * | 1986-10-03 | 1989-09-27 | Glaxo Group Limited | Indole derivatives |
US4847281A (en) * | 1986-11-21 | 1989-07-11 | Glaxo Group Limited | Method of medical treatment of addiction |
EP0279114A1 (en) * | 1986-11-21 | 1988-08-24 | Glaxo Group Limited | Medicaments for the treatment or prevention of the withdrawal syndrome |
EP0278161A1 (en) * | 1986-11-21 | 1988-08-17 | Glaxo Group Limited | Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome |
WO1988003801A1 (en) * | 1986-11-21 | 1988-06-02 | Glaxo Group Limited | Medicaments for treatment or prevention of withdrawal syndrome |
AU608788B2 (en) * | 1986-11-21 | 1991-04-18 | Glaxo Group Limited | Medicaments for the treatment of addiction |
FR2611366A1 (en) * | 1986-11-28 | 1988-09-02 | Glaxo Group Ltd | NOVEL TRICYCLIC CETONES USEFUL AS MEDICAMENTS, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION |
US5202343A (en) * | 1986-11-28 | 1993-04-13 | Glaxo Group Limited | Tricyclic ketones useful as HT3 -receptor antagonists |
EP0269452A2 (en) * | 1986-11-28 | 1988-06-01 | Glaxo Group Limited | Use of ketone derivatives for the manufacture of medicaments |
US4822881A (en) * | 1986-11-28 | 1989-04-18 | Glaxo Group Limited | Tetrahydro carbazolone intermediates |
BE1001004A4 (en) * | 1986-11-28 | 1989-06-06 | Glaxo Group Ltd | New ketones tricyclic useful as drugs, and intermediate to process their preparation. |
EP0269452A3 (en) * | 1986-11-28 | 1989-03-15 | Glaxo Group Limited | Use of ketone derivatives for the manufacture of medicaments |
EP0275669A1 (en) * | 1986-12-17 | 1988-07-27 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
EP0275668A3 (en) * | 1986-12-17 | 1989-10-11 | Glaxo Group Limited | Use of ketone derivatives in the treatment of cognitive disorders |
US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US4835173A (en) * | 1986-12-17 | 1989-05-30 | Glaxo Group Limited | Method of medical treatment |
US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
EP0278173B1 (en) * | 1986-12-17 | 1993-11-03 | Glaxo Group Limited | Use of heterocyclic derivatives in the treatment of depressions |
US4845115A (en) * | 1986-12-17 | 1989-07-04 | Glaxo Group Limited | Method of medical treatment |
AU618520B2 (en) * | 1986-12-17 | 1992-01-02 | Glaxo Group Limited | Medicaments |
EP0275668A2 (en) * | 1986-12-17 | 1988-07-27 | Glaxo Group Limited | Use of ketone derivatives in the treatment of cognitive disorders |
EP0278173A2 (en) * | 1986-12-17 | 1988-08-17 | Glaxo Group Limited | Use of heterocyclic derivatives in the treatment of depressions |
US4918080A (en) * | 1987-04-14 | 1990-04-17 | Glaxo Group Limited | Imidazollyl containing ketone derivatives |
EP0295836A2 (en) * | 1987-06-16 | 1988-12-21 | Btg International Limited | Use of dioxopiperidine derivatives for the manufacture of topical medicaments as analgesics |
EP0295836A3 (en) * | 1987-06-16 | 1989-07-19 | National Research Development Corporation | Use of dioxopiperidine derivatives as analgesics |
FR2617713A1 (en) * | 1987-07-11 | 1989-01-13 | Sandoz Sa | NEW USE OF 5HT-3 ANTAGONISTS |
DE3822792A1 (en) * | 1987-07-11 | 1989-01-19 | Sandoz Ag | Use of 5-HT3 antagonists |
AT401615B (en) * | 1987-07-11 | 1996-10-25 | Sandoz Ag | USE OF SPECIAL 5HT3 ANTAGONISTS FOR THE PRODUCTION OF MEDICINAL PRODUCTS |
US4918079A (en) * | 1987-10-02 | 1990-04-17 | Beecham Group P.L.C. | Imidazole derivatives as 5-HT3 receptor antagonists |
US4892872A (en) * | 1987-10-22 | 1990-01-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoxazine compounds and pharmaceutical use thereof |
EP0317088A1 (en) * | 1987-10-22 | 1989-05-24 | Glaxo Group Limited | Ketone derivatives |
US4939144A (en) * | 1987-10-22 | 1990-07-03 | Glaxo Group Limited | Tricyclic ketone derivatives as 5-HT antagonists |
US5225431A (en) * | 1987-10-23 | 1993-07-06 | Burroughs Wellcome Co. | Therapeutic substituted indole compounds and compositions thereof |
FR2627986A1 (en) * | 1988-03-04 | 1989-09-08 | Glaxo Group Ltd | PHARMACEUTICAL COMPOSITION OF 1,2,3,9-TETRAHYDRO-9-METHYL-3 - ((2-METHYL-1H-IMIDAZOL-1-YL) METHYL) -4H-CARBAZOL-4-ONE OR ONE OF ITS SALTS AND DEXAMETHASONE, PREPARATION METHOD AND USES THEREOF |
AT400301B (en) * | 1988-03-04 | 1995-12-27 | Glaxo Group Ltd | ANTIEMETIC |
BE1002255A5 (en) * | 1988-03-04 | 1990-11-06 | Glaxo Group Ltd | DRUGS. |
US5116984A (en) * | 1988-04-07 | 1992-05-26 | Glaxo Group Limited | Imidazole derivatives |
EP0338650A1 (en) * | 1988-04-22 | 1989-10-25 | Duphar International Research B.V | New imidazolylmethyl-cycloalkane(b)indolones |
EP0339959A3 (en) * | 1988-04-27 | 1991-03-20 | Glaxo Group Limited | Lactam derivatives |
EP0339959A2 (en) * | 1988-04-27 | 1989-11-02 | Glaxo Group Limited | Lactam derivatives |
EP0345956B1 (en) * | 1988-05-20 | 1994-03-16 | Glaxo Group Limited | Tricyclic ketones |
US5045545A (en) * | 1988-05-27 | 1991-09-03 | Glaxo Group Limited | [(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activity |
EP0361317A3 (en) * | 1988-09-27 | 1991-07-24 | Fujisawa Pharmaceutical Co., Ltd. | Pyridoindole derivatives and processes for preparation thereof |
US5290785A (en) * | 1988-09-27 | 1994-03-01 | Fujisawa Pharmaceutical Co., Ltd. | Therapeutic agent for ischemic diseases |
US5141945A (en) * | 1988-09-27 | 1992-08-25 | Fujisawa Pharmaceutical Company, Ltd. | Pyridoindole derivatives and processes for preparation thereof |
EP0361317A2 (en) * | 1988-09-27 | 1990-04-04 | Fujisawa Pharmaceutical Co., Ltd. | Pyridoindole derivatives and processes for preparation thereof |
EP0373061A1 (en) * | 1988-12-06 | 1990-06-13 | Adir Et Compagnie | Indole derivatives, process for their preparation and pharmaceutical compositions containing them |
FR2639944A1 (en) * | 1988-12-06 | 1990-06-08 | Adir | NOVEL INDOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
EP0377238A1 (en) * | 1988-12-22 | 1990-07-11 | Duphar International Research B.V | New annelated indolo (3,2-c)-lactams |
US5223625A (en) * | 1988-12-22 | 1993-06-29 | Duphar International Research B.V. | Annelated indolo [3,2,-C]lactams |
EP0376624A1 (en) * | 1988-12-22 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | 4,5,6,7-Tetrahydrobenzimidazole derivatives and their preparation |
EP0392663A1 (en) * | 1989-03-13 | 1990-10-17 | Ono Pharmaceutical Co., Ltd. | Carboline derivative as a 5-HT3 receptor antagonist |
WO1990012569A1 (en) * | 1989-04-21 | 1990-11-01 | Sandoz Ag | Therapeutic use of 5-ht3 receptor antagonists |
US5622720A (en) * | 1989-06-28 | 1997-04-22 | Glaxo Group Limited | Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
EP0411901A3 (en) * | 1989-08-01 | 1992-09-02 | Glaxo Group Limited | Treatment of conditions involving excessive eating |
US5276050A (en) * | 1989-08-01 | 1994-01-04 | Glaxo Group Limited | Medicaments |
EP0411901A2 (en) * | 1989-08-01 | 1991-02-06 | Glaxo Group Limited | Treatment of conditions involving excessive eating |
US5126343A (en) * | 1989-09-11 | 1992-06-30 | G. D. Searle & Co. | N-azabicyclo [3.3.0]octane amides of aromatic acids |
WO1991005783A1 (en) | 1989-10-14 | 1991-05-02 | John Wyeth & Brother Limited | Heterocyclic compounds |
WO1991009593A2 (en) * | 1989-12-21 | 1991-07-11 | Beecham Group Plc | 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability |
WO1991009593A3 (en) * | 1989-12-21 | 1991-09-05 | Beecham Group Plc | 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability |
EP0451538A2 (en) * | 1990-03-19 | 1991-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Use of pyridoindole derivatives in the treatment of ischemic disorders |
EP0451538A3 (en) * | 1990-03-19 | 1992-04-15 | Fujisawa Pharmaceutical Co., Ltd. | Use of pyridoindole derivatives in the treatment of ischemic disorders |
US5187166A (en) * | 1990-07-31 | 1993-02-16 | Nisshin Flour Milling Co., Ltd. | Azabicyclo derivatives and their use as antiemetics |
EP0591434A1 (en) * | 1991-06-26 | 1994-04-13 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
US5470868A (en) * | 1991-06-26 | 1995-11-28 | Sepracor Inc. | Methods for treating emesis and nausea using optically pure R(+) ondansetron |
US5712302A (en) * | 1991-06-26 | 1998-01-27 | Sepracor Inc. | Compositions using optically pure R(+) ondansetron |
US5629333A (en) * | 1991-06-26 | 1997-05-13 | Sepracor Inc. | Method treating cognitive disorders using optically pure R(+) ondansetron |
EP1022025A3 (en) * | 1991-06-26 | 2002-06-05 | Sepracor, Inc. | Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron |
EP1022025A2 (en) * | 1991-06-26 | 2000-07-26 | Sepracor, Inc. | Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron |
US5962494A (en) * | 1991-06-26 | 1999-10-05 | Sepracor Inc. | Methods for treating behavioral and other disorders using optically pure R(+) ondansetron |
EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
US5391549A (en) * | 1992-03-12 | 1995-02-21 | Mitsubishi Kasei Corporation | Cinnoline-3-carboxylic acid derivatives |
US5556851A (en) * | 1992-03-12 | 1996-09-17 | Mitsubishi Chemical Corporation | Cinnoline-3-carboxylic acid derivatives |
EP0595111A1 (en) * | 1992-10-14 | 1994-05-04 | Richter Gedeon Vegyeszeti Gyar R.T. | Carbazolone derivatives and process for preparing the same |
EP0688216A1 (en) * | 1993-03-08 | 1995-12-27 | Fujisawa Pharmaceutical Co., Ltd. | Medicament for treating or preventing cerebrovascular diseases |
GB2279008A (en) * | 1993-05-25 | 1994-12-21 | Glaxo Lab Sa | Compositions |
GB2279008B (en) * | 1993-05-25 | 1997-06-18 | Glaxo Lab Sa | Ondansetron for rectal administration |
GB2325408A (en) * | 1994-06-28 | 1998-11-25 | Kenneth Francis Prendergast | Chewing gum formulation comprising ondansetron for combat use |
GB2325408B (en) * | 1994-06-28 | 1999-01-27 | Kenneth Francis Prendergast | Chewing gum formulation comprising ondansetron |
BE1009458A5 (en) * | 1994-11-22 | 1997-04-01 | Glaxo Wellcome Inc | Pharmaceutical oral liquid containing imidazolecarbazolone. |
FR2727015A1 (en) * | 1994-11-22 | 1996-05-24 | Glaxo Wellcome Inc | ONDANSETRON LIQUID PHARMACEUTICAL COMPOSITIONS |
US5854270A (en) * | 1994-11-22 | 1998-12-29 | Glaxo Wellcome Inc. | Oral compositions containing ondansetron |
WO1996015786A3 (en) * | 1994-11-22 | 1996-06-27 | Glaxo Wellcome Inc | Oral compositions containing ondansetron |
WO1996015786A2 (en) * | 1994-11-22 | 1996-05-30 | Glaxo Wellcome Inc. | Oral compositions containing ondansetron |
GB2295317B (en) * | 1994-11-22 | 1998-11-25 | Glaxo Wellcome Inc | Liquid composition containing ondansetron |
GB2295317A (en) * | 1994-11-22 | 1996-05-29 | Glaxo Wellcome Inc | Liquid composition containing ondansetron |
EP0768309A1 (en) * | 1995-10-13 | 1997-04-16 | Duphar International Research B.V | Process for the preparation of enantiomerically pure imidazolyl compounds |
US6365743B1 (en) | 1995-10-13 | 2002-04-02 | Duphar International Research B.V. | Process for the preparation of enantiomerically pure imidazolyl compounds |
US6649183B2 (en) | 1999-03-01 | 2003-11-18 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron |
US6548082B1 (en) | 1999-03-01 | 2003-04-15 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron |
EP1207160A1 (en) * | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
US7098345B2 (en) | 2002-04-29 | 2006-08-29 | TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one |
NL1022893C2 (en) * | 2003-01-09 | 2004-07-13 | Synthon Bv | Forms of ondansetron and processes for making these. |
FR2849852A1 (en) * | 2003-01-09 | 2004-07-16 | Synthon Bv | ONDANSETRON FORMS AND PROCESS FOR THEIR PREPARATION |
WO2004063189A1 (en) * | 2003-01-09 | 2004-07-29 | Synthon B.V. | Ondansetron forms and processes of making the same |
GB2398071A (en) * | 2003-01-24 | 2004-08-11 | Synthon Bv | Preparation of ondansetron |
GB2398071B (en) * | 2003-01-24 | 2006-06-07 | Synthon Bv | Process for making ondansetron and intermediate thereof |
WO2005080381A1 (en) * | 2004-01-21 | 2005-09-01 | Inke, S.A. | New polymorphic forms of ondansetron, processes for preparing them, pharmaceutical compositions containing them and their use as antiemetics |
WO2007004041A2 (en) * | 2005-07-05 | 2007-01-11 | Orchid Research Laboratories Limited | New compounds and their pharmaceutical use |
WO2007004041A3 (en) * | 2005-07-05 | 2007-03-22 | Orchid Res Lab Ltd | New compounds and their pharmaceutical use |
EP2253316A1 (en) | 2009-05-20 | 2010-11-24 | INSERM (Institut National de la Santé et de la Recherche Medicale) | serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of vestibular deficits |
WO2010133663A1 (en) | 2009-05-20 | 2010-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
US8580730B2 (en) | 2009-05-20 | 2013-11-12 | (Inserm) Institut National De La Sante Et De La Recherche Medicale | Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2153821A (en) | 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives | |
US4695578A (en) | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances | |
EP0191562B1 (en) | Tetrahydrocarbazolone derivatives | |
EP0210840B1 (en) | Substituted imidazolylmethyltetrahydro-carbazolones | |
AU613662B2 (en) | Lactam derivatives | |
US4725615A (en) | Carbazole derivatives and their use as 5HT-induced antagonists | |
US4985422A (en) | Lactam derivatives | |
US5045545A (en) | [(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activity | |
EP0242973B1 (en) | Indole derivatives, method for their preparation and pharmaceutical compositions containing them | |
US5013733A (en) | Lactam derivatives | |
EP0266899A2 (en) | Indole derivatives | |
US4950681A (en) | Ketone derivatives | |
US5006544A (en) | Imidazole derivatives and pharmaceutical use thereof | |
US5116984A (en) | Imidazole derivatives | |
EP0291172B1 (en) | Ketone derivatives | |
US5008272A (en) | Lactam derivatives | |
US4963546A (en) | Ketone derivatives which are antagonists of 5-HT at 5-HT3 receptors, compositions containing them, and method of use | |
US4939144A (en) | Tricyclic ketone derivatives as 5-HT antagonists | |
EP0276163B1 (en) | Indole derivatives | |
CA2009745A1 (en) | Indole derivatives | |
US6127388A (en) | Azetidine, pyrrolidine and piperidine derivatives as 5-HT1D receptor agonists | |
JPS6335570A (en) | Heterocyclic compound | |
JPH0378862B2 (en) | ||
US5114950A (en) | 5,6-dihydro-N-[(imidazol-4(or 5)-yl)methyl]-4H-pyrrolo[3,2,1-IJ]quinoline-1-carboxamides having 5-HT.sub. antagonist activity | |
EP0345956B1 (en) | Tricyclic ketones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CTFF | Supplementary protection certificate filed |
Free format text: SPC/GB93/072, 930617 |
|
CTFA | Application for supplementary protection certificate granted |
Free format text: SPC/GB93/072, 931005, EXPIRES:20050222 |
|
CTFE | Supplementary protection certificate entered into force |
Free format text: SPC/GB93/072: 20050125, EXPIRES: 20050222 Spc suppl protection certif: SPC/GB93/072 Filing date: 20050125 Expiry date: 20050222 |
|
PE20 | Patent expired after termination of 20 years |
Effective date: 20050124 |
|
SPCE | Supplementary protection certificate expired |
Free format text: SPC/GB93/072, EXPIRES: 20050222 Spc suppl protection certif: SPC/GB93/072 Expiry date: 20050222 |
|
740F | Application filed by employee for compensation - according to sect. 40 | ||
740F | Application filed by employee for compensation - according to sect. 40 |